Drug Type Small molecule drug |
Synonyms GIM 407, GIM407 |
Target- |
Mechanism Treg modulator |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Georgiamune, Inc.Startup |
Active Organization Georgiamune, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | Georgiamune, Inc.Startup | 11 Aug 2023 |